Clinical characterization of lung adenocarcinoma

Clinical characterization of lung adenocarcinoma - MLADC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00012649

Enrollment

300

Registered

2017-08-18

Start date

2016-01-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34

Interventions

Group 1: Clinical data from patients undergoing surgery for lung adenocarcinoma were retrospectively analyzed. Overall and disease-free survival was evaluated via phone calls.

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: surgery on loco-regional lung adenocarcinoma between 01/2009 and 05/2015

Exclusion criteria

Exclusion criteria: lack of surgery

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
Disease-free survival	—

Countries

Germany

Contacts

Public ContactLaura Klotz

Asklepios Lungenfachklinik

laura.klotz@uni-muenchen.de089/857910

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026